Although this study found that IL23 and IL27 transcripts significantly increased in peripheral blood of breast cancer patients, the IL-23/IL-27 ratio was significantly lower in PBMCs of breast cancer patients versus healthy volunteers which may lead to the defect in anti-tumor systemic immune responses. This evidence concerns the gene IL27 and breast cancer.